High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEF ADVANCED RESEARCH PROJECTS AGCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

DARPA-PA-27-01

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AC12

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Advanced Research Projects Agency (DARPA), operating under the Department of Defense, has issued a solicitation titled "High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)" under procurement identifier DARPA-PA-27-01. This active opportunity seeks innovative proposals aimed at developing a comprehensive in-silico platform capable of mapping all protein-protein interactions. The primary objective is to advance the understanding of biological interactomes, with a particular focus on identifying novel diagnostic and therapeutic targets within the interaction space associated with conditions such as traumatic brain injury. The scope of the HUBBLE program encompasses the creation and demonstration of a high-throughput computational capability that can systematically reveal protein-protein binding landscapes. The intended outcome is to provide a transformative tool for biomedical research, enabling the discovery of previously uncharacterized molecular targets that could inform new strategies for diagnosis and treatment. Proposers are expected to deliver robust, scalable solutions that can be validated in the context of traumatic brain injury, thereby demonstrating the utility and impact of their approach. Key requirements include expertise in biotechnology research and development, specifically in computational modeling and analysis of protein interactions. The solicitation is classified under NAICS code 541714, "Research and Development in Biotechnology (except Nanobiotechnology)," and product service code AC12, indicating a focus on biomedical research and development. The program announcement has been amended to update Attachment B and clarify language in Sections 4.1.2 and 7.8, underscoring the importance of reviewing the latest documentation for compliance and proposal preparation. DARPA’s Biological Technologies Office (BTO) is the contracting entity for this initiative, with Dr. Abhishek Singharoy serving as the primary point of contact. Interested parties may direct inquiries to [email protected]. The solicitation is open for responses until November 5, 2026, at 15:11, following its posting on October 28, 2026. Contractors should note that this is a federal procurement, and the opportunity is listed on SAM.gov under Opportunity ID 7cc49984be44476e8798ab0e0c1f253b, where additional attachments and details are available. This solicitation represents a significant opportunity for organizations specializing in biotechnology research and computational biology to contribute to a high-impact federal research program. The requirements and objectives are expected to remain consistent throughout the contract lifecycle, focusing on the development, validation, and demonstration of advanced in-silico tools for mapping protein-protein interactions. Contractors are encouraged to review all provided materials and amendments to ensure alignment with program goals and compliance with submission guidelines.
Documents9